MK-8776, a Novel Chk1 Kinase Inhibitor, Radiosensitizes P53-Defective Human Tumor Cells
Oncotarget - United States
doi 10.18632/oncotarget.12311
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 28, 2016
Authors
Publisher
Impact Journals, LLC